Stay updated on Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Page version updated from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed as a minor UI change; no other substantive content changes were detected.
    Difference
    0.4%
    Check dated 2025-09-13T17:10:55.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.4%
    Check dated 2025-09-06T14:35:31.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, as well as resources related to head and neck squamous cell carcinoma. However, several key terms and drug names, including pembrolizumab and acalabrutinib, have been removed.
    Difference
    7%
    Check dated 2025-08-30T11:22:35.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T04:32:15.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-08T23:49:18.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    2%
    Check dated 2025-08-01T19:18:32.000Z thumbnail image

Stay in the know with updates to Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial page.